A

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Director – Strategic Pricing and Contracting Analytics

Corporate Finance & FP&AConfirmed live in the last 24 hours
Full-timeRemote in USA$195.5k - $264.5k /yrRemote

About the Job

Requirements

  • At least 10 years of experience in pharmaceutical, biotechnology, healthcare consulting, market access, commercial operations, finance, or related analytical functions.
  • Demonstrated experience supporting strategic pricing, contracting, market access, reimbursement, or gross-to-net decision-making.
  • Deep understanding of U.S. payer, provider, specialty pharmacy, distribution, and alternate site-of-care channels, including financial and operational drivers affecting access and contracting strategies.
  • Strong knowledge of U.S. healthcare reimbursement, payer dynamics, and market access strategies.
  • Demonstrated expertise in gross-to-net, average selling price, contract performance, and pricing analytics.
  • Ability to lead teams and influence decisions through data-driven insights.
  • Experience supporting executive governance and strategic decision-making processes.
  • Track record of developing innovative analytical capabilities, dashboards, automation solutions, and business intelligence tools.
  • Financial modeling, problem-solving, and communication skills.
  • Experience in rare disease and medical benefit buy-and-bill portfolios.

Responsibilities

  • Lead financial evaluation and deal modeling for pricing and contracting proposals to support business decisions and account strategy development through pricing and contracting governance reviews.
  • Inform gross-to-net and average selling price forecasting, budgeting, contracting strategy, and contract performance assessments.
  • Partner with Finance, Accounting, Account teams, Government Pricing, Legal, and Advanced Analytics to align data, model assumptions, and reporting.
  • Serve as the Strategic Pricing and Contracting lead for Market Access and enterprise data initiatives.
  • Develop and maintain dashboards, scorecards, and reporting tools that provide visibility into contracting performance, customer trends, and business outcomes.
  • Identify, evaluate, and implement new technologies, artificial intelligence solutions, automation capabilities, and process improvements.
  • Establish and maintain data standards, reporting methodologies, and analytical best practices for contracting analysis.
  • Generate actionable business insights supporting pricing, contracting, reimbursement, and access decisions.
  • Enhance organizational capabilities related to contracting operations, modeling, reporting, and business intelligence.

Desired Qualifications

  • Experience with rare disease portfolios.

About the Company

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Alnylam Pharmaceuticals develops RNA interference (RNAi) therapeutics to silence disease-causing genes, aiming to treat rare genetic disorders. Its products work by using RNA molecules that block gene expression, reducing the impact of specific genetic diseases. The company differentiates itself by concentrating on RNAi-based drugs for rare diseases and by building a pipeline through large clinical programs and strategic partnerships, such as commercialization deals in the Gulf States and collaborations with investors. Revenue comes from approved drug sales, licensing agreements, strategic collaborations, and related services like genetic testing and counseling. The company’s goal is to advance and commercialize RNAi therapies to improve outcomes for patients with genetic disorders, expanding its portfolio through partnerships and investments.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2002

Recently Posted Jobs

Explore more opportunities at Alnylam Pharmaceuticals

See more jobs